[ad_1]
anilakkus/iStock through Getty Photographs
Cellular-health Community Options (MNDR), a Singapore-based telehealth options supplier, has filed for a $10M U.S. preliminary public providing.
The corporate mentioned in an SEC submitting that it was seeking to provide 2.25M shares priced between $4 and $5, which might increase round $10M if priced on the midpoint. Underwriters can be granted a 45-day possibility to purchase as much as 337,500 extra shares to cowl any over-allotments.
Cellular-health hopes to checklist its shares on Nasdaq beneath the image MNDR. Community 1 Options is serving as lead bookrunner.
Promoting shareholders plan to supply as much as 3.1M extra shares. The corporate wouldn’t see any proceeds from these gross sales.
Cellular-health has been working within the pink. For 2023, the corporate reported a internet lack of $3.2M on income of $7.9M.
Current healthcare IPOs embody Chromocell (CHRO), Telomir (TELO), Metagenomi (MGX) and Kyverna (KYTX).
Extra on healthcare IPOS
Chromocell inventory down 11% following $7M IPO
Telomir Prescription drugs inventory falls 29% following $7M IPO
Moderna-backed Metagenomi sees inventory fall 31% after $94M IPO
Kyverna Therapeutics inventory rallies 59% following $319M IPO
[ad_2]
Source link
